Physician Awareness of FDA’s Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic

Drug Safety 2026

View at publisher
Authors: Catherine S. Hwang, Zhigang Lu, Massimiliano Russo, Heidi Zakoul, Gita A. Toyserkani, Esther H. Zhou, Cynthia LaCivita, Gerald J. Dal Pan, Aaron Seth Kesselheim, Ameet Sarpatwari
DOI: 10.1007/s40264-025-01634-6
Cited by: 0
References: 17

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Healthcare Regulation Pharmacy and Medical Practices

Publication details

Journal / source
Drug Safety
Volume
49
Issue
5
Pages
519–528
Publication date
28 January 2026
Language
EN